These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants]. Rodríguez Arenas MA, Barrio Anta G, de la Fuente de Hoz L, Royuela L. Rev Clin Esp; 1997 Dec; 197(12):804-9. PubMed ID: 9477670 [Abstract] [Full Text] [Related]
9. [Levels of evidence in drug therapy for alcohol use disorders and illicit drug use]. Burucker J, Kropp S. Fortschr Neurol Psychiatr; 2012 Dec; 80(12):684-93. PubMed ID: 23229101 [Abstract] [Full Text] [Related]
18. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, Johnston J. Drug Alcohol Depend; 2006 Jul 27; 83(3):210-7. PubMed ID: 16343810 [Abstract] [Full Text] [Related]
19. Evidence for selective executive function deficits in ecstasy/polydrug users. Fisk JE, Montgomery C. J Psychopharmacol; 2009 Jan 27; 23(1):40-50. PubMed ID: 18515461 [Abstract] [Full Text] [Related]
20. Mental disorders in current and former heavy ecstasy (MDMA) users. Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A. Addiction; 2005 Sep 27; 100(9):1310-9. PubMed ID: 16128720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]